1. Ahn, S., Bredow, T., dan Yu, F. 2017. Effects Of Nonpharmacological Treatments On
Quality Of Life In Parkinson’s Disease. Innovation in Aging.
(https://doi.org/10.1093/geroni/igx004.1184)
2. Bentea, E., Verbruggen, L., dan Massie, A. 2017. The Proteasome Inhibition Model
of Parkinson’s Disease. Journal of Parkinson’s Disease, 7(1), hal. 31– 63.
(https://doi.org/10.3233/JPD-160921.)
3. R. A. Hauser, 2018. Parkinson Disease,
https://emedicine.medscape.com/article/1831191-overview#a4
4. NICE Guideline, 2016, Parkinson's disease in adults: diagnosis and management, 1-
36
5. Hickey, M. Stacy, 2016, Deep Brain Stimulation: A Paradigm Shifting Approach to
Treat Parkinson's Disease, 10 (173) 1-11.
6. J. Barnes, A. Lewthwaite, et al. 2017. Parkinson’s Disease Prescribing Guidelines
for use in Primary and Secondary Care, NHS Dudley Formulary.
7. Stoker, T. B., Torsney, K. M., dan Barker, R. A. 2018. Emerging treatment
approaches for Parkinson’s disease. Frontiers in Neuroscience.
(https://doi.org/10.3389/fnins.2018.00693.)
8. Oliveira de Carvalho, A., Filho, A. S. S., Murillo-Rodriguez, E., Rocha, N. B., Carta,
M. G., dan Machado, S. 2018. Physical Exercise For Parkinson’s Disease : Clinical
And Experimental Evidence. Clinical Practice dan Epidemiology in Mental Health.
(https://doi.org/10.2174/1745017901814010089)
9. Chen, L., Wang, X. and Chen, L. (2018) „Cognitive Function in Early and Advanced
Parkinson‟s disease‟, Neuropsychiatry (London), 8, pp. 513– 518.